Intracellular bacteria differentially regulated endothelial cytokine release by MAPK-dependent histone modification

Journal of Immunology

Volumn 175, Issue 5, 2005, Pages 2843-2850

  Schmeck, Bernd ^a   Beermann, Wiebke ^a   Van Laak, Vincent ^a   Zahlten, Janine ^a   Opitz, Bastian ^a   Witzenrath, Martin ^a   Hocke, Andreas C ^a   Chakraborty, Trinad ^b   Kracht, Michael ^c   Rosseau, Simone ^a   Suttorp, Norbert ^a   Hippenstiel, Stefan ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GAMMA INTERFERON; GROWTH FACTOR; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE 1; HISTONE H3; HISTONE H4; INTERLEUKIN 8; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHOSPHOTRANSFERASE; SERINE; TRICHOSTATIN A;

ACETYLATION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME INHIBITION; EPIGENETICS; EUKARYOTE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNITY; LISTERIA INNOCUA; LISTERIA MONOCYTOGENES; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TH1 CELL; TH2 CELL; TIME; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 23844549198     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.5.2843     Document Type: Article

References (64)

1. Flo, T. H., O. Halaas, E. Lien, L. Ryan, G. Teti, D. T. Golenbock, A. Sundan, and T. Espevik. 2000. Human Toll-like receptor 2 mediates monocyte activation by Listeria monocywgenes, but not by group B streptococci or lipopolysaccharide. J. Immunol. 164: 2064-2069.
2. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-823.
3. Krull, M., R. Nost, S. Hippenstiel, E. Domann, T. Chakraborty, and N. Suttorp. 1997. Listeria monocytogenes potently induces up-regulation of endothelial adhesion molecules and neutrophil adhesion to cultured human endothelial cells. J. Immunol. 159: 1970-1976.
4. Kayal, S., A. Lilienbaum, C. Poyart, S. Memet, A. Israel, and P. Berche. 1999. Listeriolysin O-dependent activation of endothelial cells during infection with Listeria monocytogenes: activation of NF-κB and upregulation of adhesion molecules and chemokines. Mol Microbiol. 31: 1709-1722.
5. Rose, F., S. A. Zeller, T. Chakraborty, E. Domann, T. Machleidt, M. Kronke, W. Seeger, F. Grimminger, and U. Sibelius. 2001. Human endothelial cell activation and mediator release in response to Listeria monocytogenes virulence factors. Infect. Immun. 69: 897-905.
6. Czuprynski, C. J., J. F. Brown, N. Maroushek, R. D. Wagner, and H. Steinberg. 1994. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J. Immunol. 152: 1836-1846.
7. Harty, J. T., and M. J. Bevan. 1995. Specific immunity to Listeria monocytogenes in the absence of IFNγ. Immunity 3: 109-117.
8. Roesler, J., B. Kofink, J. Wendisch, S. Heyden, D. Paul, W. Friedrich, J. L. Casanova, W. Leupold, M. Gahr, and A. Rosen-Wolff. 1999. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-γ-receptor (IFNγR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp. Hematol. 27: 1368-1374.
9. Rogers, H. W., and E. R. Unanue. 1993. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect. Immun. 61: 5090-5096.
10. Schwarzer, N., R. Nost, J. Seybold, S. K. Parida, O. Fuhrmann, M. Krull, R. Schmidt, R. Newton, S. Hippenstiel, E. Domann, et al. 1998. Two distinct phospholipases C of Listeria monocytogenes induce ceramide generation, nuclear factor-κB activation, and E-selectin expression in human endothelial cells. J. Immunol. 161: 3010-3018.
11. Portnoy, D. A., R. D. Schreiber, P. Connelly, and L. G. Tilney. 1989. γ Interferon limits access of Listeria monocytogenes to the macrophage cytoplasm. J. Exp. Med. 170: 2141-2146.
12. H cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 3: 643-651.
13. Muegge, K. 2002. Preparing the target for the bullet. Nat. Immunol 3: 16-17.
14. Strahl, B. D., and C. D. Allis. 2000. The language of covalent histone modifications. Nature 403: 41-45.
15. Claus, R., and M. Lubbert. 2003. Epigenetic targets in hematopoietic malignancies. Oncogens 22: 6489-6496.
16. Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293: 1074-1080.
17. Saccani, S., S. Pantano, and G. Natoli. 2002. p38-Dependent marking of inflammatory genes for increased NF-κB recruitment. Nat. Immunol. 3: 69-75.
18. Soloaga, A., S. Thomson, G. R. Wiggin, N. Rampersaud, M. H. Dyson, C. A. Hazzalin, L. C. Mahadevan, and J. S. Arthur. 2003. MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J. 22: 2788-2797.
19. Saccani, S., and G. Natoli. 2002. Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev. 16: 2219-2224.
20. Hippenstiel, S., S. Soeth, B. Kellas, O. Fuhrmann, J. Seybold, M. Krull, C. Eichel-Streiber, M. Goebeler, S. Ludwig, and N. Suttorp. 2000. Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood 95: 3044-3051.
21. Hippenstiel, S., B. Schmeck, J. Seybold, M. Krull, C. Eichel-Streiber, and N. Suttorp. 2002. Reduction of tumor necrosis factor-α (TNF-α) related nuclear factor-κB (NF-κB) translocation but not inhibitor κ-B (Iκ-B)-degradation by Rho protein inhibition in human endothelial cells. Biochem. Pharmacol. 64: 971-977.
22. Schmeck, B., M. Brunsch, J. Seybold, M. Krull, C. Eichel-Streiber, N. Suttorp, and S. Hippenstiel. 2003. Rho protein inhibition blocks cyclooxygenase-2 expression by proinflammatory mediators in endothelial cells. Inflammation 27: 89-95.
23. Schmeck, B., J. Zahlten, K. Moog, V. van Laak, S. Huber, A. C. Hocke, B. Opitz, E. Hoffmann, M. Kracht, J. Zerrahn, et al. 2004. Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor. J. Biol. Chem. 279: 53241-53247.
24. Schmeck, B., R. Gross, P. D. N'Guessan, A. C. Hocke, S. Hammerschmidt, T. J. Mitchell, S. Rosseau, N. Suttorp, and S. Hippenstiel. 2004. Streptococcus pneumoniae-induced caspase 6-dependent apoptosis in lung epithelium. Infect. Immun. 72: 4940-4947.
25. Opitz, B., A. Puschel, B. Schmeck, A. C. Hocke, S. Rosseau, S. Hammerschmidt, R. R. Schumann, N. Suttorp, and S. Hippenstiel. 2004. Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J. Biol. Chem. 279: 36426-36432.
26. Conlan, J. W., and R. J. North. 1994. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J. Exp. Med. 179: 259-268.
27. North, R. J. 1970. The relative importance of blood monocytes and fixed macrophages to the expression of cell-mediated immunity to infection. J. Exp. Med. 132: 521-534.
28. Cheung, P., C. D. Allis, and P. Sassone-Corsi. 2000. Signaling to chromatin through histone modifications. Cell 103: 263-271.
29. Mizzen, C. A., and C. D. Allis. 1998. Linking histone acetylation to transcriptional regulation. Cell. Mol. Life Sci. 54: 6-20.
30. Turner, B. M. 2002. Cellular memory and the histone code. Cell 111: 285-291.
31. Wu, C. 1997. Chromatin remodeling and the control of gene expression. J. Biol. Chem. 272: 28171-28174.
32. Imhof, A., and A. P. Wolffe. 1998 Transcription: gene control by targeted histone acetylation. Curr. Biol. 8: R422-R424.
33. Agalioti, T., G. Chen, and D. Thanos. 2002. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111: 381-392.
34. Crosio, C., E. Heitz, C. D. Allis, E. Borrelli, and P. Sassone-Corsi. 2003. Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons. J. Cell Sci. 116: 4905-4914.
35. Li, J., M. Gorospe, J. Barnes, and Y. Liu. 2003. Tumor promoter arsenite stimulates histone H3 phosphoacetylation of proto-oncogenes c-fos and c-jun chromatin in human diploid fibroblasts. J. Biol Chem. 278: 13183-13191.
36. Salvador, L. M., Y. Park, J. Cottom, E. T. Maizels, J. C. Jones, R. V. Schillace, D. W. Carr, P. Cheung, C. D. Allis, J. L. Jameson, and M. Hunzicker-Dunn. 2001. Follicle-stimulating hormone stimulates protein kinase A-mediated histone H3 phosphorylation and acetylation leading to select gene activation in ovarian granulosa cells. J. Biol. Chem. 276: 40146-40155.
37. Barratt, M. J., C. A. Hazzalin, E. Cano, and L. C. Mahadevan. 1994. Mitogen-stimulated phosphorylation of histone H3 is targeted to a small hyperacetylation-sensitive fraction. Proc. Natl. Acad. Sci. USA 91: 4781-4785.
38. Cheung, P., K. G. Tanner, W. L. Cheung, P. Sassone-Corsi, J. M. Denu, and C. D. Allis. 2000. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell 5: 905-915.
39. Lo, W. S., R. C. Trievel, J. R. Rojas, L. Duggan, J. Y. Hsu, C. D. Allis, R. Marmorstein, and S. L. Berger. 2000. Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol. Cell 5: 917-926.
40. Haller, D., L. Holt, S. C. Kim, R. F. Schwabe, R. B. Sartor, and C. Jobin. 2003. Transforming growth factor-β1 inhibits non-pathogenic Gram negative bacteria-induced NF-κB recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. J. Biol. Chem. 278: 23851-23860.
41. Stricter, R. M. 2002. Interleukin-8: a very important chemokine of the human airway epithelium. Am. J. Physiol Lung Cell Mol. Physiol 283: L688-L689.
42. Hoshimoto, A., Y. Suzuki, T. Katsuno, H. Nakajima, and Y. Saito. 2002. Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A. Br. J. Pharmacol. 136: 280-286.
43. Ashburner, B. P., S. D. Westerheide, and A. S. Baldwin, Jr. 2001. The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell Biol. 21: 7065-7077.
44. Saklatvala, J. 2004. The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr. Opin. Pharmacol. 4: 372-377.
45. Roux, P. P., and J. Blenis. 2004. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68: 320-344.
46. Kumar, S., J. Boehm, and J. C. Lee. 2003. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2: 717-726.
47. Hazzalin, C. A., and L. C. Mahadevan. 2002. MAPK-regulated transcription: a continuously variable gene switch? Nat. Rev. Mol. Cell Biol. 3: 30-40.
48. Krull, M., J. Kramp, T. Petrov, A. C. Klucken, A. C. Hocke, C. Walter, B. Schmeck, J. Seybold, M. Maass, S. Ludwig, et al. 2004. Differences in cell activation by Chlamydophila pneumoniae and Chlamydia trachomatis infection in human endothelial cells. Infect. Immun. 72: 6615-6621.
49. Kawasaki, H., L. Schiltz, R. Chiu, K. Itakura, K. Taira, Y. Nakatani, and K. K. Yokoyama. 2000. ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature 405: 195-200.
50. Zhong, S. P., W. Y. Ma, and Z. Dong. 2000. ERKs and p38 kinases mediate ultraviolet B-induced phosphorylation of histone H3 at serine 10. J. Biol. Chem. 275: 20980-20984.
51. He, Z., W. Y. Ma, G. Liu, Y. Zhang, A. M. Bode, and Z. Dong. 2003. Arsenite-induced phosphorylation of histone H3 at serine 10 is mediated by Akt1, extracellular signal-regulated kinase 2, and p90 ribosomal S6 kinase 2 but not mitogen- and stress-activated protein kinase 1. J. Biol Chem. 278: 10588-10593.
52. Bode, A. M., and Z. Dong. 2005. Inducible covalent posttranslational modification of histone H3. Sci. STKE 2005: re4.
53. Clayton, A. L., S. Rose, M. J. Barratt, and L. C. Mahadevan. 2000. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. EMBO J. 19: 3714-3726.
54. Yamamoto, Y., U. N. Verma, S. Prajapati, Y. T. Kwak, and R. B. Gaynor. 2003. Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 423: 655-659.
55. Lomvardas, S., and D. Thanos. 2001. Nucleosome sliding via TBP DNA binding in vivo. Cell 106: 685-696.
56. Lo, W. S., E. R. Gamache, K. W. Henry, D. Yang, L. Pillus, and S. L. Berger. 2005. Histone H3 phosphorylation can promote TBP recruitment through distinct promoter-specific mechanisms. EMBO J. 24: 997-1008.
57. Legube, G., and D. Trouche. 2003. Regulating histone acetyltransferases and deacetylases. EMBO Rep. 4: 944-947.
58. Zhang, S., and M. H. Kaplan. 2000. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-γ expression. J. Immunol. 165: 1374-1380.
59. Rincon, M., H. Enslen, J. Raingeaud, M. Recht, T. Zapton, M. S. Su, L. A. Penix, R. J. Davis, and R. A. Flavell. 1998. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17: 2817-2829.
60. Stetson, D. B., M. Mohrs, R. L. Reinhardt, J. L. Baron, Z. E. Wang, L. Gapin, M. Kronenberg, and R. M. Locksley. 2003. Constitutive cytokine mRNAs mark natural killer (NK) and NKT cells poised for rapid effector function, J. Exp. Med. 198: 1069-1076.
61. Bream, J. H., D. L. Hodge, R. Gonsky, R. Spolski, W. J. Leonard, S. Krebs, S. Targan, A. Morinobu, J. J. O'Shea, and H. A. Young. 2004. A distal region in the interferon-γ gene is a site of epigenetic remodeling and transcriptional regulation by interleukin-2. J. Biol. Chem. 279: 41249-41257.
62. Tato, C. M., G. A. Martins, F. A. High, C. B. DiCioccio, S. L. Reiner, and C. A. Hunter. 2004. Cutting edge: innate production of IFN-γ by NK cells is independent of epigenetic modification of the IFN-y promoter. J. Immunol. 173: 1514-1517.
63. Kurihara, T., G. Warr, J. Loy, and R. Bravo. 1997. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186: 1757-1762.
64. Serbina, N. V., W. Kuziel, R. Flavell, S. Akira, B. Rollins, and E. G. Pamer. 2003. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity 19: 891-901.